LIFE SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2023-04-20 ms5000001229064995 来自湖南省

偏重的研究方向：心血管疾病;房颤
经验分享：文章类型：Review
4.15 submit
4.16 with editor
4.18 Under Review
4.19 第一个审稿人接受审稿

48 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2023-10-25 1304372fcam 来自北京

偏重的研究方向：脑病;基础研究
经验分享：10.2投稿
10.4under review
10.5送外审
10.23 外审结束
正在等待一审结果

25 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2024-02-19 Rambo 来自北京

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：中药提取物
经验分享：2月16号投稿
2月18号Decision in Process

21 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2024-03-29 ms3000000983513178 来自湖北省

不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。

3 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2024-05-21 ms3000000047970676

偏重的研究方向：肿瘤基础
经验分享：综述，修回半个月了，还在under review

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2024-04-27 ms1000001525252032 来自四川省

两天了还在submitted to journal，是不是需要所有作者确认啊

8 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2024-02-26 侍郎来自安徽省

请问大家life sciences这个杂志必须要三次重复的WB图吗？

20 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2024-04-06 ms1000000596177006 来自山东省

请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况

9 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2024-04-20 ms2000001471285364 来自湖北省

请问现在一定要三次wb全膜吗？

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2127319, encodeId=c40e212e3192c, content=偏重的研究方向：心血管疾病;房颤 经验分享：文章类型：Review 4.15 submit 4.16 with editor 4.18 Under Review 4.19 第一个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bd78523149, createdName=ms5000001229064995, createdTime=Thu Apr 20 19:31:40 CST 2023, time=2023-04-20, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向：脑病;基础研究 经验分享：10.2投稿 10.4under review 10.5送外审 10.23 外审结束 正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2205780, encodeId=04cd2205e8094, content=偏重的研究方向：肿瘤基础 经验分享：综述，修回半个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98c58755125, createdName=ms3000000047970676, createdTime=Tue May 21 07:52:43 CST 2024, time=2024-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200654, encodeId=def82200654a4, content=两天了还在submitted to journal，是不是需要所有作者确认啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8628244632, createdName=ms1000001525252032, createdTime=Sat Apr 27 01:55:37 CST 2024, time=2024-04-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2199463, encodeId=274721994631f, content=请问现在一定要三次wb全膜吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4039126481, createdName=ms2000001471285364, createdTime=Sat Apr 20 16:17:17 CST 2024, time=2024-04-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=2024-04-17, status=1, ipAttribution=重庆)]

2024-04-17 ms4000000067455992 来自重庆

偏重的研究方向：肿瘤学
经验分享：刚投稿，希望能在5月前接到ur

12 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务